Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy
- PMID: 8569085
- DOI: 10.1038/ki.1995.407
Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy
Abstract
Unilateral ureteral obstruction (UUO) leads to fibrosis of the obstructed kidney. We tested the hypothesis that interstitial fibrosis in UUO results, at least in part, from enhanced expression of transforming growth factor-beta (TGF-beta) which in turn is regulated by local angiotensin II (Ang II) generation. (The generic name TGF-beta is used to discuss properties shared by all isoforms, but special reference to other isoforms is made when specifically needed.) Using Northern blot and immunohistochemical analysis, we examined the expression of TGF-beta in rat kidneys after 24 hours (aUUO) and one week (cUUO) of obstruction. Obstructed kidneys from both periods had increased interstitial and perivascular TGF-beta immunoreactivity compared to contralateral and sham kidneys, in which immunostaining was confined to the inner medulla. Relative abundance of all TGF-beta mRNA isoforms were higher in the obstructed than in contralateral and sham kidneys in both aUUO and cUUO. Expression of TGF-beta isoforms varied according to site (cortex vs. medulla), segment of the nephron, type of cells and duration of the obstruction. The increase in TGF-beta immunoreactivity and mRNA levels in aUUO and cUUO was almost totally abolished by pretreatment with losartan. We conclude that in UUO: (a) TGF-beta gene expression is increased and differentially regulated; (b) Ang II, at least partially, mediates the overexpression of TGF-beta gene; and (c) Ang II may play a central role in fibrogenesis in this and other models of tubulointerstitial disease.
Similar articles
-
Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction.Am J Physiol. 1995 Jun;268(6 Pt 2):F1117-23. doi: 10.1152/ajprenal.1995.268.6.F1117. Am J Physiol. 1995. PMID: 7611452
-
Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction.Kidney Int. 2004 Jun;65(6):2091-107. doi: 10.1111/j.1523-1755.2004.00643.x. Kidney Int. 2004. PMID: 15149322
-
Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy.Am J Physiol. 1993 May;264(5 Pt 2):F874-81. doi: 10.1152/ajprenal.1993.264.5.F874. Am J Physiol. 1993. PMID: 8498541
-
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.Am J Kidney Dis. 1995 Jul;26(1):141-6. doi: 10.1016/0272-6386(95)90167-1. Am J Kidney Dis. 1995. PMID: 7611245 Review.
-
Urinary tract obstruction.Semin Nephrol. 2001 Mar;21(2):133-45. doi: 10.1053/snep.2001.20942. Semin Nephrol. 2001. PMID: 11245776 Review.
Cited by
-
Dr. Manuel Martinez-Maldonado: A Pioneer in Renal Therapeutics and Mentor to a Generation of Minority Physician-Scientists.Cureus. 2024 Sep 6;16(9):e68776. doi: 10.7759/cureus.68776. eCollection 2024 Sep. Cureus. 2024. PMID: 39246634 Free PMC article. Review.
-
Local renin-angiotensin systems in the genitourinary tract.Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan;385(1):13-26. doi: 10.1007/s00210-011-0706-y. Epub 2011 Nov 13. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22080395 Review.
-
Upregulation of Cortical Renin and Downregulation of Medullary (Pro)Renin Receptor in Unilateral Ureteral Obstruction.Front Pharmacol. 2019 Nov 14;10:1314. doi: 10.3389/fphar.2019.01314. eCollection 2019. Front Pharmacol. 2019. PMID: 31803050 Free PMC article.
-
Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression.Clin Exp Nephrol. 2020 Mar;24(3):205-215. doi: 10.1007/s10157-019-01804-8. Epub 2019 Nov 1. Clin Exp Nephrol. 2020. PMID: 31677062
-
Temporal changes in renal endoglin and TGF-beta1 expression following ureteral obstruction in rats.J Physiol Biochem. 2005 Sep;61(3):457-67. doi: 10.1007/BF03168452. J Physiol Biochem. 2005. PMID: 16440600
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous